Cargando…

Erratum to ‘Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni’ [IJP Drugs Drug Resist. 8 (2018) 559–570]

Detalles Bibliográficos
Autores principales:	Padalino, Gilda, Ferla, Salvatore, Brancale, Andrea, Chalmers, Iain W., Hoffmann, Karl F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620711/ https://www.ncbi.nlm.nih.gov/pubmed/31299537 http://dx.doi.org/10.1016/j.ijpddr.2019.07.001

Ejemplares similares

Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni
por: Padalino, Gilda, et al.
Publicado: (2018)

Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase
por: Gaba, Sonam, et al.
Publicado: (2014)

Bidding adieu IJP
por: Prakash, Shiv
Publicado: (2009)

Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes
por: Padalino, Gilda, et al.
Publicado: (2023)

Breaking the ice: IJP on homosexuality
por: Kalra, Gurvinder
Publicado: (2012)

(Epi)genetic Inheritance in Schistosoma mansoni: A Systems Approach
por: Cosseau, Céline, et al.
Publicado: (2017)

Drug-Induced Exposure of Schistosoma mansoni Antigens SmCD59a and SmKK7
por: Reimers, Natalie, et al.
Publicado: (2015)

Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activities
por: Padalino, Gilda, et al.
Publicado: (2020)

Schistosoma mansoni α-N-acetylgalactosaminidase (SmNAGAL) regulates coordinated parasite movement and egg production
por: Hulme, Benjamin J., et al.
Publicado: (2022)

Crystal Structure of Schistosoma mansoni Arginase, a Potential Drug Target for the Treatment of Schistosomiasis
por: Hai, Yang, et al.
Publicado: (2014)

SCORE Studies on the Impact of Drug Treatment on Morbidity due to Schistosoma mansoni and Schistosoma haematobium Infection
por: King, Charles H., et al.
Publicado: (2020)

Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni
por: Cowan, Noemi, et al.
Publicado: (2015)

Antibody responses to Schistosoma mansoni schistosomula antigens
por: Egesa, Moses, et al.
Publicado: (2018)

Schistosoma mansoni Larval Extracellular Vesicle protein 1 (SmLEV1) is an immunogenic antigen found in EVs released from pre-acetabular glands of invading cercariae
por: Gasan, Thomas A., et al.
Publicado: (2021)

Histone methylation changes are required for life cycle progression in the human parasite Schistosoma mansoni
por: Roquis, David, et al.
Publicado: (2018)

Cheminformatics in Natural Product‐based Drug Discovery
por: Chen, Ya, et al.
Publicado: (2020)

Drug Target Exploitable Structural Features of Adenylyl Cyclase Activity in Schistosoma mansoni
por: Mbah, Andreas N., et al.
Publicado: (2012)

In-silico screening of Schistosoma mansoni Sirtuin1 inhibitors for prioritization of drug candidates
por: Singh, Raghvendra, et al.
Publicado: (2016)

Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
por: Panic, Gordana, et al.
Publicado: (2015)

Toward Mass Drug Administration Stopping Criteria for Schistosoma mansoni Control Programs
por: Secor, W. Evan
Publicado: (2019)

In silico repositioning of approved drugs against Schistosoma mansoni energy metabolism targets
por: Calixto, Nicole Melo, et al.
Publicado: (2018)

Activity of Combinations of Antioxidants and Anthelmintic Drugs against the Adult Stage of Schistosoma mansoni
por: Gouveia, Maria João, et al.
Publicado: (2020)

Multihost Transmission of Schistosoma mansoni in Senegal, 2015–2018
por: Catalano, Stefano, et al.
Publicado: (2020)

Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
por: Geyer, Kathrin K., et al.
Publicado: (2011)

Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone
por: Sesay, Santigie, et al.
Publicado: (2014)

Oxamniquine resistance alleles are widespread in Old World Schistosoma mansoni and predate drug deployment
por: Chevalier, Frédéric D., et al.
Publicado: (2019)

High-resolution AP-SMALDI MSI as a tool for drug imaging in Schistosoma mansoni
por: Mokosch, Annika S., et al.
Publicado: (2021)

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of Schistosoma mansoni and Schistosoma haematobium Infection in Africa
por: King, Charles H., et al.
Publicado: (2020)

Novel Computing Technologies for Bioinformatics and Cheminformatics
por: Tang, Chuan Yi, et al.
Publicado: (2014)

The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets
por: Whatley, Kezia C. L., et al.
Publicado: (2019)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
por: Caffrey, Conor R., et al.
Publicado: (2009)

Schistogram changes after administration of antischistosomal drugs in mice at the early phase of Schistosoma mansoni infection
por: Vimieiro, Andréa Cássia Simões, et al.
Publicado: (2013)

Development and Validation of a Luminescence-based, Medium-Throughput Assay for Drug Screening in Schistosoma mansoni
por: Lalli, Cristiana, et al.
Publicado: (2015)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

Schistosoma mansoni schistosomula antigens induce Th1/Pro‐inflammatory cytokine responses
por: Egesa, Moses, et al.
Publicado: (2018)

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021)

Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target
por: Kuntz, Angela N, et al.
Publicado: (2007)

Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug
por: Mwangi, Ibrahim N., et al.
Publicado: (2014)

The effects of subcurative praziquantel treatment on life‐history traits and trade‐offs in drug‐resistant Schistosoma mansoni
por: Viana, Mafalda, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6sqtn0ivdlchu24ojrn1c8eclr